MMWR recomm. rep; 72 (34), 2023

A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms of the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV)-associated lower respiratory tract infecti...

Texto completo

MMWR recomm. rep; 72 (34), 2023

A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms for the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV))-associated lower respiratory tract infec...

Texto completo

Evidence-based recommendations on eptinezumab (VYEPTI) for preventing migraine in adults. Commercial arrangement There is a simple discount patient access scheme for eptinezumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact United...

Texto completo

La enfermedad por el Coronavirus 2019 (COVID-19) es una patología respiratoria de humanos producida por SARS-CoV-2. El 11 de marzo de 2020 la Organización Mundial de la Salud (OMS) declaró al COVID-19 como una pandemia, y desde ese momento se han reportado en Argentina más de 3.000.000 casos confirma...

Texto completo